Pharmacia & Upjohn
Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Adrucil | Fluorouracil | 1991-06-28 | ||
| Alphadrol | Fluprednisolone | 1982-01-01 | ||
| Ansaid | Flurbiprofen | 1988-10-31 | ||
| Azulfidine | Sulfasalazine | 1982-01-01 | ||
| Baciguent | Bacitracin | 1982-01-01 | ||
| Berubigen | Cyanocobalamin | 1982-01-01 | 2024 | — |
| Bextra | Valdecoxib | 2003-03-27 | ||
| Caduet | Amlodipine besylate, Atorvastatin | 2004-01-30 | 2037 | |
| Calmurid | Hydrocortisone, Urea | 1982-01-01 | 2032-2034 | |
| Cardrase | Ethoxzolamide | 1982-01-01 | — | |
| Cleocin | Clindamycin | 1982-01-01 | 2024-2040 |
1
2
3
4
5
6
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use